AGÕæÈ˹ٷ½

STOCK TITAN

[Form 4] CARGO Therapeutics, Inc. Insider Trading Activity

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
4
Rhea-AI Filing Summary

On 20 June 2025, Udemy, Inc. (UDMY) filed a Form 4 reporting that independent director Sohaib Abbasi was granted 27,476 restricted stock units (RSUs) on 17 June 2025 under the company’s outside-director compensation policy. The grant is coded “Aâ€� (acquisition) at a price of $0, indicating a share-based award rather than an open-market purchase. Abbasi’s direct beneficial ownership increases to 97,365 common shares following the transaction.

The RSUs vest in full on the earlier of (i) Udemy’s next annual shareholder meeting or (ii) one year from the grant date, provided Abbasi continues to serve as a director. He has additionally elected to defer settlement until the earlier of 1 January 2029 or his separation from the board, signalling a long-term alignment with shareholder interests. The award represents less than 0.02 % of shares outstanding and is therefore immaterial from a dilution perspective. Overall, this is a routine insider compensation disclosure with no expected impact on Udemy’s fundamental outlook.

Il 20 giugno 2025, Udemy, Inc. (UDMY) ha presentato un Modulo 4 segnalando che il direttore indipendente Sohaib Abbasi ha ricevuto 27.476 unità di azioni vincolate (RSU) il 17 giugno 2025, secondo la politica di compensazione per direttori esterni della società. L’assegnazione è classificata come “A� (acquisizione) a un prezzo di $0, indicando un premio basato su azioni anziché un acquisto sul mercato aperto. La proprietà diretta effettiva di Abbasi aumenta a 97.365 azioni ordinarie dopo la transazione.

Le RSU maturano completamente al verificarsi del primo evento tra (i) la prossima assemblea annuale degli azionisti di Udemy o (ii) un anno dalla data di assegnazione, a condizione che Abbasi continui a ricoprire il ruolo di direttore. Ha inoltre scelto di posticipare la liquidazione fino al primo evento tra il 1° gennaio 2029 o la sua uscita dal consiglio, dimostrando un allineamento a lungo termine con gli interessi degli azionisti. Il premio rappresenta meno dello 0,02% delle azioni in circolazione ed è quindi irrilevante dal punto di vista della diluizione. In generale, si tratta di una comunicazione di routine riguardante la compensazione interna senza impatti attesi sul profilo fondamentale di Udemy.

El 20 de junio de 2025, Udemy, Inc. (UDMY) presentó un Formulario 4 informando que el director independiente Sohaib Abbasi °ù±ð³¦¾±²ú¾±Ã³ 27,476 unidades restringidas de acciones (RSU) el 17 de junio de 2025 bajo la política de compensación para directores externos de la empresa. La concesión está codificada como “Aâ€� (adquisición) a un precio de $0, lo que indica una asignación basada en acciones en lugar de una compra en el mercado abierto. La propiedad directa beneficiaria de Abbasi aumenta a 97,365 acciones comunes tras la transacción.

Las RSU se consolidan en su totalidad en la fecha que ocurra primero entre (i) la próxima junta anual de accionistas de Udemy o (ii) un año desde la fecha de concesión, siempre que Abbasi continúe como director. Además, ha elegido diferir el pago hasta la fecha que ocurra primero entre el 1 de enero de 2029 o su separación de la junta, señalando un alineamiento a largo plazo con los intereses de los accionistas. La concesión representa menos del 0,02% de las acciones en circulación y por tanto es insignificante desde una perspectiva de dilución. En conjunto, se trata de una divulgación rutinaria de compensación interna sin impacto esperado en la perspectiva fundamental de Udemy.

2025ë…� 6ì›� 20ì�, Udemy, Inc. (UDMY)ëŠ� ë…립 ì´ì‚¬ Sohaib Abbasiê°€ 2025ë…� 6ì›� 17ì� 회사ì� 외부 ì´ì‚¬ ë³´ìƒ ì •ì±…ì—� ë”°ë¼ 27,476 제한 ì£¼ì‹ ë‹¨ìœ„(RSU)ë¥� 부여받았ìŒì� 보고하는 Form 4ë¥� 제출했습니다. ì� 부여는 ê°€ê²©ì´ $0ì� “Aâ€�(ì·¨ë“) 코드ë¡� 표시ë˜ì–´ 공개 시장 구매가 아닌 ì£¼ì‹ ê¸°ë°˜ ë³´ìƒì� ì˜ë¯¸í•©ë‹ˆë‹�. ì� 거래 í›� Abbasiì� ì§ì ‘ 실질 소유ê¶�ì¶Ä 97,365 보통ì£�ë¡� ì¦ê°€í•©ë‹ˆë‹�.

RSUëŠ� (i) Udemyì� ë‹¤ìŒ ì—°ë¡€ 주주ì´íšŒ ë˜ëŠ” (ii) 부여ì¼ë¡œë¶€í„� 1ë…� ì¤� 먼저 ë„래하는 시ì ì—� ì „ì•¡ 베스íŒ�ë˜ë©°, Abbasiê°€ ê³„ì† ì´ì‚¬ë¡� 재ì§í•˜ëŠ” 조건입니ë‹�. 그는 ë˜í•œ ì •ì‚°ì� 2029ë…� 1ì›� 1ì� ë˜ëŠ” ì´ì‚¬íšŒì—ì„� 퇴임하는 ì‹œì  ì¤� 먼저 ë„래하는 때까지 연기하기ë¡� ì„ íƒí•˜ì—¬ 주주 ì´ìµê³� 장기ì ìœ¼ë¡� ì¼ì¹˜í•˜ëŠ” ì˜ì§€ë¥� 나타냈습니다. ì� ë³´ìƒì¶Ä 발행 주ì‹ì� 0.02% 미만ì—� 해당하여 í¬ì„ ê´€ì ì—ì„� 중요하지 않습니다. ì „ë°˜ì ìœ¼ë¡� ì´ëŠ” Udemyì� 기본 ì „ë§ì—� ì˜í–¥ì� 미치지 않는 ì¼ìƒì ì¸ ë‚´ë¶€ìž� ë³´ìƒ ê³µì‹œìž…ë‹ˆë‹�.

Le 20 juin 2025, Udemy, Inc. (UDMY) a déposé un formulaire 4 indiquant que le directeur indépendant Sohaib Abbasi s’est vu attribuer 27 476 unités d’actions restreintes (RSU) le 17 juin 2025 dans le cadre de la politique de rémunération des administrateurs externes de la société. L’attribution est codée « A » (acquisition) à un prix de 0 $, ce qui indique une attribution en actions plutôt qu’un achat sur le marché libre. La propriété directe bénéficiaire d’Abbasi augmente à 97 365 actions ordinaires suite à la transaction.

Les RSU deviennent entièrement acquises au premier des deux événements suivants : (i) la prochaine assemblée annuelle des actionnaires d’Udemy ou (ii) un an à compter de la date d’attribution, à condition qu’Abbasi continue de siéger en tant qu’administrateur. Il a également choisi de différer le règlement jusqu’au premier des deux événements : le 1er janvier 2029 ou sa sortie du conseil, ce qui témoigne d’un alignement à long terme avec les intérêts des actionnaires. Cette attribution représente moins de 0,02 % des actions en circulation et est donc négligeable du point de vue de la dilution. Dans l’ensemble, il s’agit d’une divulgation de rémunération interne de routine sans impact attendu sur les perspectives fondamentales d’Udemy.

Am 20. Juni 2025 reichte Udemy, Inc. (UDMY) ein Formular 4 ein, in dem berichtet wurde, dass der unabhängige Direktor Sohaib Abbasi am 17. Juni 2025 27.476 Restricted Stock Units (RSUs) gemäß der Vergütungspolitik für externe Direktoren des Unternehmens erhalten hat. Die Zuteilung ist mit „A� (Erwerb) zu einem Preis von $0 codiert, was auf eine aktienbasierte Vergütung und keinen Kauf am offenen Markt hinweist. Abbasis direkter wirtschaftlicher Eigentumsanteil erhöht sich nach der Transaktion auf 97.365 Stammaktien.

Die RSUs werden vollständig zum früheren Zeitpunkt von (i) Udemys nächster jährlicher Hauptversammlung oder (ii) einem Jahr ab dem Zuteilungsdatum fällig, vorausgesetzt, Abbasi bleibt im Amt. Zudem hat er sich entschieden, die Abrechnung bis zum früheren Zeitpunkt vom 1. Januar 2029 oder seinem Ausscheiden aus dem Vorstand aufzuschieben, was auf eine langfristige Ausrichtung an den Interessen der Aktionäre hinweist. Die Zuteilung entspricht weniger als 0,02 % der ausstehenden Aktien und ist daher aus Verwässerungssicht unerheblich. Insgesamt handelt es sich um eine routinemäßige Offenlegung der Insidervergütung ohne erwartete Auswirkungen auf die fundamentale Perspektive von Udemy.

Positive
  • Director ownership increases, reinforcing alignment with shareholders.
  • Full-deferral of RSU settlement until 2029 or separation supports long-term governance focus.
Negative
  • None.

Insights

TL;DR: Routine RSU grant; aligns director incentives, negligible dilution, neutral corporate impact.

The Form 4 simply documents Udemy’s standard outside-director equity compensation. A 27,476-share RSU grant has an estimated value of roughly low-seven figures, but against Udemy’s ±148 million shares outstanding it poses no meaningful dilution. By deferring settlement until 2029 or board departure, Abbasi ties his upside to the company’s longer-term performance, an alignment positive for governance. However, there is no operational, strategic or financial signal in the filing, nor any change to board composition. I therefore view the disclosure as neutral for investors.

Il 20 giugno 2025, Udemy, Inc. (UDMY) ha presentato un Modulo 4 segnalando che il direttore indipendente Sohaib Abbasi ha ricevuto 27.476 unità di azioni vincolate (RSU) il 17 giugno 2025, secondo la politica di compensazione per direttori esterni della società. L’assegnazione è classificata come “A� (acquisizione) a un prezzo di $0, indicando un premio basato su azioni anziché un acquisto sul mercato aperto. La proprietà diretta effettiva di Abbasi aumenta a 97.365 azioni ordinarie dopo la transazione.

Le RSU maturano completamente al verificarsi del primo evento tra (i) la prossima assemblea annuale degli azionisti di Udemy o (ii) un anno dalla data di assegnazione, a condizione che Abbasi continui a ricoprire il ruolo di direttore. Ha inoltre scelto di posticipare la liquidazione fino al primo evento tra il 1° gennaio 2029 o la sua uscita dal consiglio, dimostrando un allineamento a lungo termine con gli interessi degli azionisti. Il premio rappresenta meno dello 0,02% delle azioni in circolazione ed è quindi irrilevante dal punto di vista della diluizione. In generale, si tratta di una comunicazione di routine riguardante la compensazione interna senza impatti attesi sul profilo fondamentale di Udemy.

El 20 de junio de 2025, Udemy, Inc. (UDMY) presentó un Formulario 4 informando que el director independiente Sohaib Abbasi °ù±ð³¦¾±²ú¾±Ã³ 27,476 unidades restringidas de acciones (RSU) el 17 de junio de 2025 bajo la política de compensación para directores externos de la empresa. La concesión está codificada como “Aâ€� (adquisición) a un precio de $0, lo que indica una asignación basada en acciones en lugar de una compra en el mercado abierto. La propiedad directa beneficiaria de Abbasi aumenta a 97,365 acciones comunes tras la transacción.

Las RSU se consolidan en su totalidad en la fecha que ocurra primero entre (i) la próxima junta anual de accionistas de Udemy o (ii) un año desde la fecha de concesión, siempre que Abbasi continúe como director. Además, ha elegido diferir el pago hasta la fecha que ocurra primero entre el 1 de enero de 2029 o su separación de la junta, señalando un alineamiento a largo plazo con los intereses de los accionistas. La concesión representa menos del 0,02% de las acciones en circulación y por tanto es insignificante desde una perspectiva de dilución. En conjunto, se trata de una divulgación rutinaria de compensación interna sin impacto esperado en la perspectiva fundamental de Udemy.

2025ë…� 6ì›� 20ì�, Udemy, Inc. (UDMY)ëŠ� ë…립 ì´ì‚¬ Sohaib Abbasiê°€ 2025ë…� 6ì›� 17ì� 회사ì� 외부 ì´ì‚¬ ë³´ìƒ ì •ì±…ì—� ë”°ë¼ 27,476 제한 ì£¼ì‹ ë‹¨ìœ„(RSU)ë¥� 부여받았ìŒì� 보고하는 Form 4ë¥� 제출했습니다. ì� 부여는 ê°€ê²©ì´ $0ì� “Aâ€�(ì·¨ë“) 코드ë¡� 표시ë˜ì–´ 공개 시장 구매가 아닌 ì£¼ì‹ ê¸°ë°˜ ë³´ìƒì� ì˜ë¯¸í•©ë‹ˆë‹�. ì� 거래 í›� Abbasiì� ì§ì ‘ 실질 소유ê¶�ì¶Ä 97,365 보통ì£�ë¡� ì¦ê°€í•©ë‹ˆë‹�.

RSUëŠ� (i) Udemyì� ë‹¤ìŒ ì—°ë¡€ 주주ì´íšŒ ë˜ëŠ” (ii) 부여ì¼ë¡œë¶€í„� 1ë…� ì¤� 먼저 ë„래하는 시ì ì—� ì „ì•¡ 베스íŒ�ë˜ë©°, Abbasiê°€ ê³„ì† ì´ì‚¬ë¡� 재ì§í•˜ëŠ” 조건입니ë‹�. 그는 ë˜í•œ ì •ì‚°ì� 2029ë…� 1ì›� 1ì� ë˜ëŠ” ì´ì‚¬íšŒì—ì„� 퇴임하는 ì‹œì  ì¤� 먼저 ë„래하는 때까지 연기하기ë¡� ì„ íƒí•˜ì—¬ 주주 ì´ìµê³� 장기ì ìœ¼ë¡� ì¼ì¹˜í•˜ëŠ” ì˜ì§€ë¥� 나타냈습니다. ì� ë³´ìƒì¶Ä 발행 주ì‹ì� 0.02% 미만ì—� 해당하여 í¬ì„ ê´€ì ì—ì„� 중요하지 않습니다. ì „ë°˜ì ìœ¼ë¡� ì´ëŠ” Udemyì� 기본 ì „ë§ì—� ì˜í–¥ì� 미치지 않는 ì¼ìƒì ì¸ ë‚´ë¶€ìž� ë³´ìƒ ê³µì‹œìž…ë‹ˆë‹�.

Le 20 juin 2025, Udemy, Inc. (UDMY) a déposé un formulaire 4 indiquant que le directeur indépendant Sohaib Abbasi s’est vu attribuer 27 476 unités d’actions restreintes (RSU) le 17 juin 2025 dans le cadre de la politique de rémunération des administrateurs externes de la société. L’attribution est codée « A » (acquisition) à un prix de 0 $, ce qui indique une attribution en actions plutôt qu’un achat sur le marché libre. La propriété directe bénéficiaire d’Abbasi augmente à 97 365 actions ordinaires suite à la transaction.

Les RSU deviennent entièrement acquises au premier des deux événements suivants : (i) la prochaine assemblée annuelle des actionnaires d’Udemy ou (ii) un an à compter de la date d’attribution, à condition qu’Abbasi continue de siéger en tant qu’administrateur. Il a également choisi de différer le règlement jusqu’au premier des deux événements : le 1er janvier 2029 ou sa sortie du conseil, ce qui témoigne d’un alignement à long terme avec les intérêts des actionnaires. Cette attribution représente moins de 0,02 % des actions en circulation et est donc négligeable du point de vue de la dilution. Dans l’ensemble, il s’agit d’une divulgation de rémunération interne de routine sans impact attendu sur les perspectives fondamentales d’Udemy.

Am 20. Juni 2025 reichte Udemy, Inc. (UDMY) ein Formular 4 ein, in dem berichtet wurde, dass der unabhängige Direktor Sohaib Abbasi am 17. Juni 2025 27.476 Restricted Stock Units (RSUs) gemäß der Vergütungspolitik für externe Direktoren des Unternehmens erhalten hat. Die Zuteilung ist mit „A� (Erwerb) zu einem Preis von $0 codiert, was auf eine aktienbasierte Vergütung und keinen Kauf am offenen Markt hinweist. Abbasis direkter wirtschaftlicher Eigentumsanteil erhöht sich nach der Transaktion auf 97.365 Stammaktien.

Die RSUs werden vollständig zum früheren Zeitpunkt von (i) Udemys nächster jährlicher Hauptversammlung oder (ii) einem Jahr ab dem Zuteilungsdatum fällig, vorausgesetzt, Abbasi bleibt im Amt. Zudem hat er sich entschieden, die Abrechnung bis zum früheren Zeitpunkt vom 1. Januar 2029 oder seinem Ausscheiden aus dem Vorstand aufzuschieben, was auf eine langfristige Ausrichtung an den Interessen der Aktionäre hinweist. Die Zuteilung entspricht weniger als 0,02 % der ausstehenden Aktien und ist daher aus Verwässerungssicht unerheblich. Insgesamt handelt es sich um eine routinemäßige Offenlegung der Insidervergütung ohne erwartete Auswirkungen auf die fundamentale Perspektive von Udemy.

SEC Form 4
FORM 4 UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Estimated average burden
hours per response: 0.5
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.
1. Name and Address of Reporting Person*
Orwin John A

(Last) (First) (Middle)
C/O CARGO THERAPEUTICS, INC.
835 INDUSTRIAL ROAD, SUITE 400

(Street)
SAN CARLOS CA 94070

(City) (State) (Zip)
2. Issuer Name and Ticker or Trading Symbol
CARGO Therapeutics, Inc. [ CRGX ]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X Director 10% Owner
Officer (give title below) Other (specify below)
3. Date of Earliest Transaction (Month/Day/Year)
06/18/2025
4. If Amendment, Date of Original Filed (Month/Day/Year)
6. Individual or Joint/Group Filing (Check Applicable Line)
X Form filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3) 2. Transaction Date (Month/Day/Year) 2A. Deemed Execution Date, if any (Month/Day/Year) 3. Transaction Code (Instr. 8) 4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5) 5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4) 6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3) 2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (Month/Day/Year) 3A. Deemed Execution Date, if any (Month/Day/Year) 4. Transaction Code (Instr. 8) 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) 6. Date Exercisable and Expiration Date (Month/Day/Year) 7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4) 8. Price of Derivative Security (Instr. 5) 9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Stock Option (Right to Buy) $4.35 06/18/2025 A 25,000 (1) 06/17/2035 Common Stock 25,000 $0 25,000 D
Explanation of Responses:
1. 100% of the shares subject to the option shall vest on the earlier of (i) the one year anniversary of June 18, 2025 or (ii) the next Annual Meeting following June 18, 2025, subject to the Reporting Person's continued service to the Issuer.
/s/ Halley Gilbert, as attorney-in-fact for John A. Orwin 06/20/2025
** Signature of Reporting Person Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Udemy (UDMY) disclose on 20 Jun 2025?

The company reported a grant of 27,476 RSUs to director Sohaib Abbasi on 17 Jun 2025.

How many Udemy shares does Sohaib Abbasi own after the RSU grant?

Abbasi now beneficially owns 97,365 common shares directly.

When will the granted RSUs vest?

They fully vest on the earlier of Udemy’s next annual meeting or one year from 17 Jun 2025.

When are the RSUs scheduled to settle into shares?

Settlement is deferred to the earlier of 1 Jan 2029 or Abbasi’s separation from the board.

Does the RSU grant materially dilute existing Udemy shareholders?

No. The 27,476 shares represent less than 0.02 % of total shares outstanding, an immaterial amount.
Cargo Therapeutics

NASDAQ:CRGX

CRGX Rankings

CRGX Latest News

CRGX Latest SEC Filings

CRGX Stock Data

189.99M
44.69M
0.24%
122.58%
7.37%
Biotechnology
Biological Products, (no Disgnostic Substances)
United States
SAN CARLOS